Brief: ReNerve Posts Full-Year Loss Attributable Of A$5.6 Million
28/08/2026 02:32
BRIEF-ReNerve Posts Full-Year Loss Attributable Of A$5.6 Million Aug 28 (Reuters) - ReNerve Ltd RNV.AX:
FY LOSS ATTRIBUTABLE A$5.6 MILLION
NO DIVIDENDS PAID, RECOMMENDED OR DECLARED DURING FY2026
Further company coverage: RNV.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Renerve
See all newsBrief: Renerve Says Positive FDA Feedback On Nervalign Nerve Guide Matrix
Brief: Renerve And Rmit Awarded A$499K Grant
Brief: ReNerve Posts Full-Year Loss Attributable Of A$5.6 Million
Brief: ReNerve Says Nervalign Nerve Cuff Receives CDSCO Marketing Approval In India
Australia's ReNerve rises on securing up to A$5 million funding facility